Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Polygonum multiflorum extract helps hair grow longer and fights the effects of hormones that cause hair loss.

Hair loss doesn't affect COVID-19 severity.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

PGD2 stops hair growth and is higher in bald men with AGA.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Male pattern baldness involves genetics, hormones, and needs better treatments.

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Lowering testosterone speeds up wound healing in male mice.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Oxidative stress affects hair loss in men with androgenetic alopecia.

Minoxidil and finasteride effectively treat hair loss.

Six new genetic regions linked to early hair loss also connect to Parkinson's disease and prostate cancer, possibly leading to new treatments.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

PRP and HF-MSCs treatment improves hair growth, thickness, and density in androgenetic alopecia.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

PRP injections may be a safe, effective alternative for hair loss treatment compared to minoxidil and finasteride.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Multiple treatments work best for hair loss.

DHT, a testosterone byproduct, causes male pattern baldness.